-+ 0.00%
-+ 0.00%
-+ 0.00%

Hemostemix Presents at Small Cap Growth Virtual Investor Conference

PUBT·11/19/2026 15:12:12
Listen to the news
Hemostemix Presents at Small Cap Growth Virtual Investor Conference
  • Hemostemix CEO Thomas Smeenk will present at the Small Cap Growth Virtual Investor Conference on November 19, 2026.
  • The presentation at 12:00 p.m. ET will highlight VesCell clinical findings supporting the proposed Phase I longevity trial.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hemostemix Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611191011NEWSFILECNPR____20261119_324886_1) on November 19, 2026, and is solely responsible for the information contained therein.